GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family

[Image: see text] Pan-BET inhibitors have shown profound efficacy in a number of in vivo preclinical models and have entered the clinic in oncology trials where adverse events have been reported. These inhibitors interact equipotently with the eight bromodomains of the BET family of proteins. To bet...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ACS Med Chem Lett
Autors principals: Preston, Alex, Atkinson, Stephen J., Bamborough, Paul, Chung, Chun-wa, Gordon, Laurie J., Grandi, Paola, Gray, James R. J., Harrison, Lee A., Lewis, Antonia J., Lugo, David, Messenger, Cassie, Michon, Anne-Marie, Mitchell, Darren J., Prinjha, Rab K., Rioja, Inmaculada, Seal, Jon, Taylor, Simon, Thesmar, Pierre, Wall, Ian D., Watson, Robert J., Woolven, James M., Demont, Emmanuel H.
Format: Artigo
Idioma:Inglês
Publicat: American Chemical Society 2020
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7429977/
https://ncbi.nlm.nih.gov/pubmed/32832027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.0c00247
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars